Increased risk of cancer due to hyperinsulinemia may be caused by both endogenous (prediabetes, metabolic syndrome, obesity, T2DM) and exogenous hyperinsulinemia (insulin therapy for diabetes mellitus) [28,280,281]. This evidence concerns the gene INS and metabolic syndrome.